Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9722 | 1062 | 31.9 | 60% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | 19 OXYGENATION | Author keyword | 17 | 100% | 1% | 8 |
2 | HUMAN PLACENTAL MICROSOME | Author keyword | 12 | 86% | 1% | 6 |
3 | HUMAN PLACENTAL MICROSOMES | Author keyword | 9 | 67% | 1% | 8 |
4 | SUICIDE SUBSTRATE | Author keyword | 8 | 34% | 2% | 20 |
5 | STEROIDAL INHIBITORS | Author keyword | 6 | 80% | 0% | 4 |
6 | 16 ALPHA HYDROXYANDROSTENEDIONE | Author keyword | 6 | 100% | 0% | 4 |
7 | 17 ALPHA HYDROXYLASE 17 20 LYASE CYP17 INHIBITORS | Author keyword | 6 | 100% | 0% | 4 |
8 | TIME DEPENDENT INACTIVATION | Author keyword | 4 | 50% | 1% | 6 |
9 | ESTUDOS FARMACEUT | Address | 3 | 16% | 2% | 20 |
10 | 17 ALPHA HYDROXYLASE C 17 C 20 LYASE | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN PLACENTAL AROMATASE | 150 | 70% | 12% | 126 |
2 | ESTROGEN BIOSYNTHESIS | 39 | 26% | 12% | 131 |
3 | P45017 ALPHA | 39 | 68% | 3% | 34 |
4 | P450 17 | 35 | 81% | 2% | 21 |
5 | STRUCTURALLY MODIFIED DERIVATIVES | 32 | 85% | 2% | 17 |
6 | HUMAN 17 ALPHA HYDROXYLASE 17 20 LYASE CYP17 | 29 | 77% | 2% | 20 |
7 | 4 ANDROSTENE 3 6 17 TRIONE | 23 | 86% | 1% | 12 |
8 | 4 HYDROXY 4 ANDROSTENE 3 17 DIONE | 21 | 85% | 1% | 11 |
9 | TETRAHYDRONAPHTHALENES | 18 | 89% | 1% | 8 |
10 | P450 AROM | 17 | 100% | 1% | 8 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Aromatase inhibitors in the treatment of breast cancer | 2005 | 214 | 133 | 37% |
Nonsteroidal aromatase inhibitors: Recent advances | 2002 | 63 | 105 | 55% |
Inhibition of CYP 17, a new strategy for the treatment of prostate cancer | 2002 | 41 | 56 | 71% |
A review of mechanistic studies on aromatase (CYP19) and 17 alpha-hydroxylase-17,20-lyase (CYP17) | 2011 | 19 | 61 | 38% |
Computational methods for the design of potent aromatase inhibitors | 2013 | 6 | 91 | 43% |
Inhibitors of 17 alpha-hydroxylase/17,20-lyase (CYP17): Potential agents for the treatment of prostate cancer | 1999 | 66 | 99 | 36% |
CYP17 inhibitors for prostate cancer treatment - An update | 2008 | 25 | 216 | 38% |
Inhibitors of steroidal cytochrome P450 enzymes as targets for drug development | 2007 | 28 | 62 | 50% |
Current status on development of steroids as anticancer agents | 2013 | 19 | 146 | 16% |
Human aromatase: Perspectives in biochemistry and biotechnology | 2013 | 4 | 65 | 45% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ESTUDOS FARMACEUT | 3 | 16% | 1.9% | 20 |
2 | HRICHTUNG PHARMAZEUT MED CHEM 12 1 | 3 | 60% | 0.3% | 3 |
3 | CNRSEP 9 | 2 | 67% | 0.2% | 2 |
4 | UP EA BIOMOL THER IES ANTITUMORALES 4021 | 2 | 67% | 0.2% | 2 |
5 | PHARMACEUT CHEM GRP | 1 | 38% | 0.3% | 3 |
6 | DRUG DISCOVERY MED CHEM 3 | 1 | 100% | 0.2% | 2 |
7 | HORMONES CANC PROGRAM | 1 | 100% | 0.2% | 2 |
8 | ENDOCRINE BIOCHEM | 1 | 21% | 0.5% | 5 |
9 | ADV STUDY PHARMACEUT SCI | 1 | 50% | 0.1% | 1 |
10 | FR PHARMACEUT MED CHEM 8 5 | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000199634 | STEROID SULFATASE//ESTRONE SULFATASE//AROMATASE |
2 | 0.0000159571 | D HOMOSTEROIDS//FUSED STEROIDS//16 17 SECOSTEROIDS |
3 | 0.0000140667 | ESTROGENIC RECRUITMENT//AMINOGLUTETHIMIDE//CYCLIC TREATMENT |
4 | 0.0000128381 | AROMATASE INHIBITORS//EXEMESTANE//ANASTROZOLE |
5 | 0.0000120222 | WESTPHALEN REARRANGEMENT//IMIDE REDUCTION//FOSSIL BIOMARKERS |
6 | 0.0000117442 | 17 ALPHA HYDROXYLASE 17 20 LYASE DEFICIENCY//17 ALPHA HYDROXYLASE DEFICIENCY//ADRENARCHE |
7 | 0.0000090233 | HOMO AZA STEROIDAL ESTERS//STEROIDAL ESTERS//HOMO AZA STEROIDS |
8 | 0.0000079160 | CYTOCHROME P450 INTERACTIONS//NONLINEAR CLEARANCE//NONLINEAR LIVER BINDING |
9 | 0.0000066870 | 17 BETA HYDROXYSTEROID DEHYDROGENASE//17 BETA HSD2//17 BETA HSD1 |
10 | 0.0000062344 | 5 ALPHA REDUCTASE//FINASTERIDE//BIOL SYST ANIM PROD |